BrivaracetamFDA Approved: * October 3, 2022
Pharm Company: * ZYDUS PHARMS USA
Brivaracetam, sold under the brand names Briviact and Brivajoy among others, a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties. It is marketed by the pharmaceutical company UCB. In India it is co-promoted and distributed by Dr. Reddy's Laboratories.[not verified in body] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.